McKesson Company Profile (NYSE:MCK)

About McKesson (NYSE:MCK)

McKesson logoMcKesson Corporation (McKesson) is engaged in delivering pharmaceuticals, medical supplies and healthcare information technology. The Company operates through two segments: McKesson Distribution Solutions and Technology Solutions. The McKesson Distribution Solutions segment distributes drugs and equipment, and health and beauty care products across North America and internationally. The Distribution Solutions segment provides pharmaceutical solutions for biotech and pharmaceutical manufacturers, and practice management, technology, clinical support and business solutions to oncology and other specialty practices operating in the community setting. The Technology Solutions segment delivers clinical, patient care, financial, supply chain and strategic management software solutions, as well as connectivity, outsourcing and other services. Its McKesson Health Solutions portfolio includes ClarityQx, which is a payment technology.

Industry, Sector and Symbol:
  • Sector: Medical
  • Industry: Drugs Wholesale
  • Sub-Industry: Health Care Distributors
  • Symbol: NYSE:MCK
  • CUSIP: 58155Q10
  • Web:
  • Market Cap: $33.71 billion
  • Outstanding Shares: 212,000,000
Average Prices:
  • 50 Day Moving Avg: $142.22
  • 200 Day Moving Avg: $144.07
  • 52 Week Range: $114.53 - $199.43
  • Trailing P/E Ratio: 7.00
  • Foreward P/E Ratio: 12.46
  • P/E Growth: 2.09
Sales & Book Value:
  • Annual Revenue: $198.53 billion
  • Price / Sales: 0.17
  • Book Value: $52.33 per share
  • Price / Book: 3.04
  • Annual Dividend: $1.12
  • Dividend Yield: 0.7%
  • EBIDTA: $4.07 billion
  • Net Margins: 0.97%
  • Return on Equity: 30.05%
  • Return on Assets: 4.69%
  • Debt-to-Equity Ratio: 0.76%
  • Current Ratio: 1.03%
  • Quick Ratio: 0.61%
  • Average Volume: 1.72 million shs.
  • Beta: 1.06
  • Short Ratio: 2.21

Frequently Asked Questions for McKesson (NYSE:MCK)

What is McKesson's stock symbol?

McKesson trades on the New York Stock Exchange (NYSE) under the ticker symbol "MCK."

How often does McKesson pay dividends? What is the dividend yield for McKesson?

McKesson announced a quarterly dividend on Wednesday, January 25th. Shareholders of record on Wednesday, March 1st will be given a dividend of $0.28 per share on Monday, April 3rd. This represents a $1.12 dividend on an annualized basis and a yield of 0.70%. The ex-dividend date is Monday, February 27th. View McKesson's Dividend History.

How were McKesson's earnings last quarter?

McKesson Co. (NYSE:MCK) posted its quarterly earnings data on Thursday, May, 18th. The company reported $3.39 earnings per share (EPS) for the quarter, topping the Zacks' consensus estimate of $3.04 by $0.35. The company had revenue of $48.71 billion for the quarter, compared to analyst estimates of $49.48 billion. McKesson had a return on equity of 30.05% and a net margin of 0.97%. The firm's revenue was up 4.4% on a year-over-year basis. During the same period in the previous year, the firm earned $2.44 EPS. View McKesson's Earnings History.

Where is McKesson's stock going? Where will McKesson's stock price be in 2017?

19 equities research analysts have issued 1-year target prices for McKesson's stock. Their predictions range from $131.00 to $211.00. On average, they expect McKesson's share price to reach $171.31 in the next twelve months. View Analyst Ratings for McKesson.

What are analysts saying about McKesson stock?

Here are some recent quotes from research analysts about McKesson stock:

  • 1. According to Zacks Investment Research, "McKesson posted stable numbers for the fourth-quarter fiscal 2017 wherein earnings beat past the Zacks Consensus Estimate owing to strong performance in the Distribution Solutions division. Over the past three months, McKesson underperformed the broader industry with respect to price performance. To boost growth the company has entered into an agreement to acquire CoverMyMeds for approximately $1.1 billion. However in the near term the company depends heavily on the pharmaceutical distribution business, which is witnessing slow growth. In addition, the company expects weaker generic pharmaceutical pricing trends in fiscal 2018. The company also anticipates lower profits in fiscal 2018 due to customer pricing activities and moderating branded pharmaceutical pricing trends. In addition, unfavorable movements in foreign exchange rates continue to hurt sales." (5/23/2017)
  • 2. Citigroup Inc analysts commented, "MCK yesterday announced the completion of its previously-announced agreement w/Change Healthcare (CHC) to create a new HCIT company retaining the same name, combining substantially all of CHC's business and the majority of MCK Tech. Solutions, less its EIS segment which will remain in MTS. Initial plans to merge assets were announced on 6/28/16. Mgmt provided color on the NewCo's financial implications, largely consistent with expectations, with recognition occurring on a 1-month lag (reducing guided F4Q17 adj EPS by ~$0.15). We update our estimates to fully reflect today's guidance on the NewCo, but currently assume a full FY18 RAD contribution to MCK. Net, we maintain our Buy, as headwinds appear to be stabilizing while the WMT contract should improve purchasing power, with some offsets given initial Change dilution and a likely F2H18 loss of RAD; $175 TP (+$6), ~13-14x CY17 EPS, ~17% ETR." (3/6/2017)
  • 3. FBR & Co analysts commented, "This morning, McKesson announced that it will combine most of its IT businesses with privately owned Change Healthcare (formerly known as Emdeon). MCK will own 70% of the new company and receive cash proceeds of $1.25 billion. MCK will continue to own the Relay Health Pharmacy operations and divest its Enterprise Information Solutions (EIS) division. The new company is expected to complete an IPO in the first half of CY17, and McKesson intends to exit its investment in the new company in a tax-efficient manner. We view the proposed transaction as a solid step to finally exiting the IT business, which the company entered in 1998. However, the ultimate impact on MCK will depend on how the new company is valued in the public equity markets and how MCK redeploys net proceeds from its potential sale." (6/29/2016)

Who are some of McKesson's key competitors?

Who owns McKesson stock?

McKesson's stock is owned by a number of of retail and institutional investors. Top institutional investors include Wellington Management Group LLP (10.72%), BlackRock Inc. (6.70%), Vanguard Group Inc. (6.62%), State Street Corp (4.65%), Massachusetts Financial Services Co. MA (2.32%) and Parnassus Investments CA (2.02%). Company insiders that own McKesson stock include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Nigel A Rees, Patrick Blake, Paul C Julian, Susan R Salka and Wayne A Budd. View Institutional Ownership Trends for McKesson.

Who sold McKesson stock? Who is selling McKesson stock?

McKesson's stock was sold by a variety of institutional investors in the last quarter, including FMR LLC, Wells Fargo & Company MN, Vanguard Group Inc., Nordea Investment Management AB, TIAA CREF Investment Management LLC, Morgan Stanley, Southpoint Capital Advisors LP and Schroder Investment Management Group. Company insiders that have sold McKesson stock in the last year include Erin M Lampert, James A Beer, John H Hammergren, Lori A Schechter, M Christine Jacobs, Marie L/Ca Knowles, Patrick Blake and Wayne A Budd. View Insider Buying and Selling for McKesson.

Who bought McKesson stock? Who is buying McKesson stock?

McKesson's stock was purchased by a variety of institutional investors in the last quarter, including BlackRock Inc., Parnassus Investments CA, Pzena Investment Management LLC, Ameriprise Financial Inc., Kiltearn Partners LLP, Alliancebernstein L.P., JPMorgan Chase & Co. and Point72 Asset Management L.P.. Company insiders that have bought McKesson stock in the last two years include Lori A Schechter and Susan R Salka. View Insider Buying and Selling for McKesson.

How do I buy McKesson stock?

Shares of McKesson can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

How much does a share of McKesson stock cost?

One share of McKesson stock can currently be purchased for approximately $159.00.

Analyst Ratings

Consensus Ratings for McKesson (NYSE:MCK) (?)
Ratings Breakdown: 1 Sell Rating, 10 Hold Ratings, 8 Buy Ratings
Consensus Rating:Hold (Score: 2.37)
Consensus Price Target: $171.31 (7.74% upside)

Analysts' Ratings History for McKesson (NYSE:MCK)
DateFirmActionRatingPrice TargetImpact on Share PriceDetails
5/23/2017JPMorgan Chase & Co.UpgradeNeutral -> Overweight$189.00MediumView Rating Details
5/19/2017Leerink SwannSet Price TargetHold$140.00HighView Rating Details
5/17/2017Jefferies Group LLCInitiated CoverageHold -> Hold$153.00MediumView Rating Details
4/27/2017Barclays PLCReiterated RatingOverweight$174.00LowView Rating Details
4/17/2017Evercore ISIReiterated RatingOutperform$166.00LowView Rating Details
4/4/2017Needham & Company LLCInitiated CoverageHoldLowView Rating Details
3/6/2017Citigroup IncBoost Price TargetBuy$169.00 -> $175.00N/AView Rating Details
3/3/2017Credit Suisse Group AGReiterated RatingSellN/AView Rating Details
1/18/2017Avondale PartnersUpgradeMarket Perform -> Outperform$157.00 -> $193.00N/AView Rating Details
1/3/2017MizuhoDowngradeBuy -> Neutral$147.00N/AView Rating Details
11/11/2016Standpoint ResearchDowngradeBuy -> HoldN/AView Rating Details
10/28/2016Deutsche Bank AGDowngradeBuy -> Hold$196.00 -> $153.00N/AView Rating Details
10/28/2016Robert W. BairdDowngradeOutperform -> Neutral$200.00 -> $164.00N/AView Rating Details
9/19/2016ArgusReiterated RatingHoldN/AView Rating Details
9/16/2016Goldman Sachs Group IncDowngradeBuy -> Neutral$210.00 -> $189.00N/AView Rating Details
7/28/2016Morgan StanleyBoost Price TargetOverweight$199.00 -> $211.00N/AView Rating Details
6/30/2016Bank of America CorpReiterated RatingHoldN/AView Rating Details
6/29/2016FBR & CoReiterated RatingBuy$210.00N/AView Rating Details
6/1/2016Raymond James Financial, Inc.DowngradeStrong-Buy -> OutperformN/AView Rating Details
3/15/2016Cowen and CompanyDowngradeOutperform -> Market Perform$208.00 -> $173.00N/AView Rating Details
3/11/2016Royal Bank of CanadaReiterated RatingBuyN/AView Rating Details
7/31/2015S&P Equity ResearchReiterated RatingBuy$268.00N/AView Rating Details
(Data available from 5/24/2015 forward)


Earnings History for McKesson (NYSE:MCK)
Earnings by Quarter for McKesson (NYSE:MCK)
Earnings History by Quarter for McKesson (NYSE:MCK)
DateQuarterConsensus EstimateActual EPSRevenue EstimateActual RevenueRelease LinkConference CallDetails
5/18/2017Q4 17$3.04$3.39$49.48 billion$48.71 billionViewN/AView Earnings Details
1/25/2017Q317$2.95$3.03$50.71 billion$50.13 billionViewN/AView Earnings Details
10/27/2016Q217$3.05$2.94$24.16 billion$49.96 billionViewListenView Earnings Details
7/27/2016Q117$3.33$3.50$50.32 billion$49.73 billionViewListenView Earnings Details
5/4/2016Q416$3.14$2.44$46.83 billion$46.68 billionViewN/AView Earnings Details
1/27/2016Q316$3.13$3.18$48.97 billion$47.90 billionViewListenView Earnings Details
10/29/2015Q216$2.99$3.31$47.85 billion$48.60 billionViewListenView Earnings Details
7/29/2015Q116$2.89$3.14$46.02 billion$47.50 billionViewListenView Earnings Details
5/12/2015Q415$2.75$2.94$45.00 billion$44.93 billionViewListenView Earnings Details
2/5/2015Q315$2.61$2.89$44.81 billion$47.01 billionViewN/AView Earnings Details
10/28/2014Q215$2.73$2.79$42.99 billion$44.76 billionViewN/AView Earnings Details
7/31/2014Q115$2.34$2.49$40.65 billion$44.06 billionViewN/AView Earnings Details
5/12/2014Q414$2.40$2.55$35.89 billion$38.14 billionViewN/AView Earnings Details
1/31/2014Q314$1.85$1.45$38.57 billion$34.30 billionViewN/AView Earnings Details
10/24/2013Q214$2.03$2.27$32.16 billion$33.00 billionViewListenView Earnings Details
7/25/2013Q1 2014$1.71$2.07$32.60 billion$32.20 billionViewListenView Earnings Details
5/7/2013Q4 2013$2.30$1.45$32.01 billion$30.62 billionViewListenView Earnings Details
1/31/2013Q3 2013$1.62$1.41$30.81 billion$31.19 billionViewListenView Earnings Details
10/25/2012$1.78$1.92ViewN/AView Earnings Details
7/26/2012$1.48$1.55ViewN/AView Earnings Details
4/30/2012$2.04$2.09ViewN/AView Earnings Details
1/30/2012$1.38$1.40ViewN/AView Earnings Details
10/25/2011$1.38$1.63ViewN/AView Earnings Details
7/28/2011$1.10$1.27ViewN/AView Earnings Details
5/3/2011$1.60$1.66ViewN/AView Earnings Details
1/31/2011$1.12$1.12ViewN/AView Earnings Details
(Data available from 1/1/2011 forward)


Earnings Estimates for McKesson (NYSE:MCK)
2017 EPS Consensus Estimate: $12.80
2018 EPS Consensus Estimate: $11.44
QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20172$3.36$3.40$3.38
Q2 20172$3.10$3.10$3.10
Q3 20172$2.85$3.46$3.16
Q4 20173$2.99$3.51$3.17
Q1 20182$2.84$2.88$2.86
Q2 20182$2.74$2.82$2.78
Q3 20182$2.75$2.80$2.78
Q4 20182$2.97$3.08$3.03
(Data provided by Zacks Investment Research)


Current Dividend Information for McKesson (NYSE:MCK)
Most Recent Dividend:4/3/2017
Annual Dividend:$1.12
Dividend Yield:0.70%
Dividend Growth:10.10% (3 Year Average)
Payout Ratio:13.25% (Trailing 12 Months of Earnings)
9.77% (Based on This Year's Estimates)
8.78% (Based on Next Year's Estimates)
Track Record:4 Years of Consecutive Dividend Growth
Dividend Payments by Quarter for McKesson (NYSE:MCK)

Dividend History by Quarter for McKesson (NYSE:MCK)
AnnouncedPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
(Data available from 1/1/2013 forward)

Insider Trades

Insider Trading and Institutional Ownership History for McKesson (NYSE:MCK)
Insider Ownership Percentage: 1.15%
Institutional Ownership Percentage: 87.81%
Insider Trades by Quarter for McKesson (NYSE:MCK)
Institutional Ownership by Quarter for McKesson (NYSE:MCK)
Insider Trades by Quarter for McKesson (NYSE:MCK)
Transaction DateInsider NameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails
3/29/2017John H HammergrenChairmanSell100,500$150.44$15,119,220.00View SEC Filing  
3/2/2017John H HammergrenChairmanSell100,500$150.49$15,124,245.00View SEC Filing  
12/5/2016Wayne A. BuddDirectorSell723$145.77$105,391.71View SEC Filing  
11/30/2016Lori A SchechterEVPBuy692$144.52$100,007.84View SEC Filing  
11/2/2016Susan R SalkaDirectorBuy1,000$136.35$136,350.00View SEC Filing  
10/31/2016Erin M LampertSVPSell921$123.99$114,194.79View SEC Filing  
10/3/2016Erin M. LampertSVPSell1,739$165.94$288,569.66View SEC Filing  
9/12/2016John H HammergrenChairmanSell100,500$180.77$18,167,385.00View SEC Filing  
9/12/2016Wayne A BuddDirectorSell2,309$179.70$414,927.30View SEC Filing  
9/6/2016John H HammergrenChairmanSell100,500$184.22$18,514,110.00View SEC Filing  
8/22/2016M Christine JacobsDirectorSell915$193.78$177,308.70View SEC Filing  
8/1/2016Marie L/Ca KnowlesDirectorSell915$192.73$176,347.95View SEC Filing  
7/14/2016James A BeerCFOSell5,500$199.00$1,094,500.00View SEC Filing  
5/25/2016John H HammergrenCEOSell37,420$182.87$6,842,995.40View SEC Filing  
5/25/2016Patrick BlakeEVPSell6,322$182.87$1,156,104.14View SEC Filing  
5/24/2016John H HammergrenCEOSell18,709$182.06$3,406,160.54View SEC Filing  
5/24/2016Lori A SchechterEVPSell107$182.06$19,480.42View SEC Filing  
5/23/2016John H HammergrenCEOSell18,718$179.33$3,356,698.94View SEC Filing  
5/23/2016Patrick BlakeEVPSell3,162$179.33$567,041.46View SEC Filing  
5/10/2016John H HammergrenCEOSell101,833$170.71$17,383,911.43View SEC Filing  
4/25/2016John H HammergrenCEOSell101,833$176.81$18,005,092.73View SEC Filing  
4/4/2016John H HammergrenCEOSell45,300$159.00$7,202,700.00View SEC Filing  
3/15/2016Nigel A ReesSVPSell6,000$157.59$945,540.00View SEC Filing  
2/2/2016Susan R SalkaDirectorBuy1,000$156.21$156,210.00View SEC Filing  
2/1/2016Lori A. SchechterEVPSell2,476$159.73$395,491.48View SEC Filing  
1/4/2016John H. HammergrenCEOSell101,833$194.11$19,766,803.63View SEC Filing  
12/1/2015John H. HammergrenCEOSell101,833$190.06$19,354,379.98View SEC Filing  
11/24/2015John H. HammergrenCEOSell56,533$190.01$10,741,835.33View SEC Filing  
10/12/2015John H. HammergrenCEOSell101,835$190.51$19,400,585.85View SEC Filing  
8/13/2015Paul C JulianEVPSell55,666$214.54$11,942,583.64View SEC Filing  
7/15/2015Paul C JulianEVPSell27,833$234.04$6,514,035.32View SEC Filing  
7/14/2015Paul C JulianEVPSell27,833$232.86$6,481,192.38View SEC Filing  
6/17/2015Paul C JulianEVPSell55,668$234.06$13,029,652.08View SEC Filing  
5/28/2015John H HammergrenCEOSell60,000$238.53$14,311,800.00View SEC Filing  
5/28/2015Lori A SchechterEVPSell1,468$238.22$349,706.96View SEC Filing  
5/26/2015John H HammergrenCEOSell30,062$238.97$7,183,916.14View SEC Filing  
5/26/2015Paul C JulianEVPSell15,289$238.97$3,653,612.33View SEC Filing  
5/22/2015Jorge FigueredoEVPSell20,775$240.11$4,988,285.25View SEC Filing  
5/15/2015Jorge FigueredoEVPSell8,525$240.00$2,046,000.00View SEC Filing  
2/17/2015Randall N SprattEVPSell44,523$225.00$10,017,675.00View SEC Filing  
2/12/2015Randall N SprattEVPSell7,477$225.00$1,682,325.00View SEC Filing  
2/10/2015Alton F Irby IIIDirectorSell5,000$220.76$1,103,800.00View SEC Filing  
2/10/2015Nigel A ReesMajor ShareholderSell9,000$220.42$1,983,780.00View SEC Filing  
1/28/2015John H HammergrenCEOSell64,521$219.52$14,163,649.92View SEC Filing  
1/26/2015Brian Scott TylerEVPSell5,431$216.62$1,176,463.22View SEC Filing  
1/26/2015John H HammergrenCEOSell35,479$219.07$7,772,384.53View SEC Filing  
1/7/2015John H HammergrenCEOSell77,100$214.00$16,499,400.00View SEC Filing  
12/8/2014John H HammergrenCEOSell12,200$214.01$2,610,922.00View SEC Filing  
11/28/2014Patrick BlakeEVPSell19,000$210.00$3,990,000.00View SEC Filing  
11/24/2014John H HammergrenCEOSell100,000$209.25$20,925,000.00View SEC Filing  
11/12/2014Paul C JulianEVPSell74,666$202.51$15,120,611.66View SEC Filing  
10/31/2014Patrick BlakeEVPSell38,000$204.68$7,777,840.00View SEC Filing  
10/8/2014Paul C JulianEVPSell74,667$195.86$14,624,278.62View SEC Filing  
10/7/2014John H HammergrenCEOSell100,000$197.28$19,728,000.00View SEC Filing  
9/10/2014Paul C JulianEVPSell74,667$196.76$14,691,478.92View SEC Filing  
8/29/2014Jorge FigueredoEVPSell24,500$195.00$4,777,500.00View SEC Filing  
8/8/2014M Christine JacobsDirectorSell2,619$189.88$497,295.72View SEC Filing  
8/5/2014Marie L/Ca KnowlesDirectorSell785$192.10$150,798.50View SEC Filing  
6/2/2014Patrick BlakeEVPSell15,000$190.00$2,850,000.00View SEC Filing  
5/29/2014Paul C JulianEVPSell21,057$186.89$3,935,342.73View SEC Filing  
5/28/2014Alton F Irby IIIDirectorSell4,000$182.73$730,920.00View SEC Filing  
5/28/2014John H HammergrenCEOSell125,596$183.31$23,023,002.76View SEC Filing  
5/28/2014Jorge FigueredoEVPSell20,542$183.30$3,765,348.60View SEC Filing  
5/27/2014Brian Scott TylerEVPSell3,916$183.30$717,802.80View SEC Filing  
5/22/2014Brian Scott TylerEVPSell8,250$184.17$1,519,402.50View SEC Filing  
3/21/2014Jorge FigueredoEVPSell23,684$185.81$4,400,724.04View SEC Filing  
3/10/2014Patrick BlakeEVPSell38,750$180.36$6,988,950.00View SEC Filing  
2/4/2014Brian Scott TylerEVPSell6,250$169.68$1,060,500.00View SEC Filing  
1/22/2014Alton Irby IIIDirectorSell1,300$167.98$218,374.00View SEC Filing  
11/1/2013Nigel A ReesCFOSell7,000$158.72$1,111,040.00View SEC Filing  
10/29/2013Brian Scott TylerEVPSell8,250$153.44$1,265,880.00View SEC Filing  
10/11/2013Brian Scott TylerEVPSell9,000$138.51$1,246,590.00View SEC Filing  
10/9/2013Paul JulianEVPSell84,000$134.04$11,259,360.00View SEC Filing  
10/8/2013Brian Scott TylerEVPSell9,000$138.00$1,242,000.00View SEC Filing  
9/11/2013Paul C JulianEVPSell84,000$126.20$10,600,800.00View SEC Filing  
8/7/2013Paul JulianEVPSell84,000$123.29$10,356,360.00View SEC Filing  
8/6/2013Marie L/Ca KnowlesDirectorSell1,223$123.54$151,089.42View SEC Filing  
7/30/2013Brian Scott TylerEVPSell6,250$123.94$774,625.00View SEC Filing  
6/19/2013Paul C JulianEVPSell84,750$114.89$9,736,927.50View SEC Filing  
6/14/2013David M LawrenceDirectorSell7,500$114.28$857,100.00View SEC Filing  
6/14/2013Jorge FigueredoEVPSell6,250$115.00$718,750.00View SEC Filing  
6/10/2013Jorge FigueredoEVPSell10,000$115.00$1,150,000.00View SEC Filing  
6/4/2013Jorge FigueredoEVPSell22,500$113.63$2,556,675.00View SEC Filing  
5/30/2013Laureen SeegerEVPSell57,750$114.89$6,634,897.50View SEC Filing  
5/29/2013John H HammergrenCEOSell230,484$115.21$26,554,061.64View SEC Filing  
5/29/2013Randall N SprattEVPSell32,226$115.21$3,712,757.46View SEC Filing  
5/28/2013Brian Scott TylerEVPSell6,023$116.33$700,655.59View SEC Filing  
5/28/2013Jeffrey C CampbellCFOSell73,102$116.33$8,503,955.66View SEC Filing  
5/24/2013Laureen SeegerEVPSell17,250$116.50$2,009,625.00View SEC Filing  
5/22/2013Laureen SeegerEVPSell17,250$118.13$2,037,742.50View SEC Filing  
5/20/2013Brian Scott TylerEVPSell5,000$117.81$589,050.00View SEC Filing  
5/15/2013Nigel A ReesVPSell8,000$116.00$928,000.00View SEC Filing  
5/10/2013Brian Scott TylerEVPSell6,250$115.59$722,437.50View SEC Filing  
5/10/2013John H HammergrenCEOSell75,000$115.30$8,647,500.00View SEC Filing  
1/18/2013Jorge FigueredoEVPSell2,500$103.22$258,050.00View SEC Filing  
1/17/2013Laureen SeegerEVPSell17,250$103.00$1,776,750.00View SEC Filing  
9/4/2012Paul C JulianEVPSell36,250$87.02$3,154,475.00View SEC Filing  
(Data available from 1/1/2013 forward)


Headline Trends for McKesson (NYSE:MCK)
Latest Headlines for McKesson (NYSE:MCK)
DateHeadline logoSpike In McKesson Prompts Vetr Downgrade To Hold - May 23 at 10:36 AM logoMcKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : May 23, 2017 - May 23 at 10:36 AM logoMcKesson Upgraded at JPMorgan - May 23 at 10:36 AM logoZacks Investment Research Upgrades McKesson Co. (MCK) to "Hold" - May 23 at 9:26 AM logoMcKesson Co. (MCK) Stock Rating Upgraded by JPMorgan Chase & Co. - May 23 at 7:38 AM logoMcKesson Co. (MCK) Stock Rating Lowered by Vetr Inc. - May 22 at 10:54 PM logoMcKesson Co. Expected to Post Q1 2018 Earnings of $2.88 Per Share (MCK) - May 22 at 7:26 AM logoMcKesson Co. (MCK) PT Set at $140.00 by Leerink Swann - May 19 at 8:28 PM logoHere's Why McKesson Corporation Stock Is Climbing Today - May 19 at 6:32 PM logoWhy Dynegy, McKesson, and Deere Jumped Today - May 19 at 6:32 PM logoUS stocks close broadly higher; oil rises - May 19 at 6:32 PM logoDynegy Energy, Ross Stores climb; Foot Locker plunges - May 19 at 5:18 PM logoHere's Why McKesson Corporation Stock Is Climbing Today - May 19 at 1:08 PM logo3 Big Stock Charts for Friday: Alibaba Group Holding Ltd (BABA), McKesson Corporation (MCK) and Analog Devices, Inc. (ADI) - May 19 at 11:46 AM logoDrug distributor McKesson's quarterly revenue rises 4.4 pct - May 19 at 11:00 AM logoMcKesson shares surge after earnings, outlook top Street view - May 19 at 11:00 AM logoMcKesson beats 4Q profit forecasts - May 19 at 11:00 AM logoAfter-hours buzz: CRM, GPS, MCK & more - May 19 at 11:00 AM logoDrug distributor McKesson's profit beats, shares jump - May 19 at 11:00 AM logoMcKesson Shares Jump After Fourth Quarter Beat - May 19 at 11:00 AM logoEdited Transcript of MCK earnings conference call or presentation 18-May-17 9:00pm GMT - May 19 at 11:00 AM logoMcKesson Co. (MCK) Issues Earnings Results - May 18 at 9:04 PM logoMcKesson Finishes a Tough Fiscal Year With Solid Momentum - May 18 at 7:58 PM logoMcKesson beats by $0.42, misses on revenue - May 18 at 4:20 PM logoAnalysts Offer Predictions for McKesson Co.'s FY2017 Earnings (MCK) - May 18 at 10:38 AM logoMcKesson Co. (MCK) Now Covered by Jefferies Group LLC - May 17 at 11:38 PM logoErvin Cohen & Jessup to host authors' event for "Slam-Dunk Success" - May 17 at 6:25 PM logoAmazon could 'break open' the pharmacy space, says health tech investor - May 17 at 6:25 PM logoEyes Are on McKesson's Guidance - May 17 at 6:25 PM logoSKYGEN USA Reaffirms Its Commitment to Reinventing the Healthcare Benefits Landscape through Hiring of Three New C-level Executives - May 16 at 10:35 AM logoMcKesson Corp. – Value Analysis (NYSE:MCK) : May 15, 2017 - May 15 at 5:51 PM logoMcKesson Co. (MCK) Given Average Rating of "Hold" by Analysts - May 15 at 2:46 PM logoMcKesson Corp. breached its 50 day moving average in a Bullish Manner : MCK-US : May 12, 2017 - May 12 at 7:05 PM logoMcKesson (MCK) Q4 Earnings: Will the Stock Disappoint? - May 12 at 7:05 PM logoBRIEF-Omnicell adds to product offerings in Canada through agreement with McKesson Canada - May 9 at 8:43 PM logoEvents for Columbus Startup Week amplify personal stories of entrepreneurs - May 5 at 6:44 PM logoVetr Inc. Lowers McKesson Co. (MCK) to Buy - May 5 at 12:12 AM logoFavorable Press Coverage Very Likely to Impact McKesson (MCK) Share Price - May 4 at 10:04 PM logoDrug wholesaler AmerisourceBergen profit beats on cost controls - May 4 at 11:44 AM logoWhat's the Next Berkshire Hathaway Acquisition? - May 2 at 7:23 PM logoMcKesson (MCK) Receives Daily Media Sentiment Score of -0.04 - May 1 at 6:00 PM logoBostonian Blood Cancer Survivor Meets Stem Cell Donor at Gift of Life 5K - May 1 at 12:43 PM logoMcKesson: Bears Still Have the Upper Hand - May 1 at 12:43 PM logo Brokerages Anticipate McKesson Co. (MCK) Will Announce Quarterly Sales of $49.86 Billion - April 29 at 10:32 AM logoArkansas will face challenges replenishing execution supply - April 29 at 8:45 AM logoPositive News Coverage Very Likely to Impact McKesson (MCK) Share Price - April 28 at 11:06 PM logoBarclays PLC Reaffirms "Overweight" Rating for McKesson Co. (MCK) - April 27 at 12:08 PM logo$3.04 Earnings Per Share Expected for McKesson Co. (MCK) This Quarter - April 27 at 9:58 AM logoSomewhat Positive Media Coverage Extremely Likely to Affect McKesson (MCK) Share Price - April 25 at 4:58 PM
News IconOne of pharma's biggest middlemen just lost a big customer — and it exposes how the industry works - April 24 at 6:50 PM



McKesson (MCK) Chart for Wednesday, May, 24, 2017

This page was last updated on 5/24/2017 by Staff